The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Read MoreCointelegraph.com News
- Home
- Ethereum News
- Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Posted in
Ethereum News
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
You May Also Like
Posted in
Ethereum News
eToro to tokenize 100 most popular US stocks on Ethereum
Posted by
admin
Posted in
Ethereum News
BitMine’s $1B repurchase plan favors shares over more ETH — for now
Posted by
admin
Posted in
Ethereum News
‘Largest’ volume skew for ETH confirms pivot to altcoins: Glassnode
Posted by
admin